ALBION FINANCIAL GROUP /UT
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 1054677
SALT LAKE CITY, UT
Position in LCTX
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$3,986
-$821 QoQ
Shares Held
3,043
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 19 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALBION FINANCIAL GROUP /UT holds $300,713 across 14 Biotechnology names. LCTX ranks #4 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
|
10,000 | $186,500 | |
| 2 | GENB |
Generate Biomedicines, Inc.
|
4,854 | $81,886 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
1,178 | $20,991 | |
| 4 | LCTX |
Lineage Cell Therapeutics, Inc.
This page
|
3,043 | $3,986 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
26 | $2,035 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
520 | $1,908 | |
| 7 | INSM |
INSMED Inc
|
13 | $1,386 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
125 | $1,223 |
All Filings in LCTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,986 | 3,043 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $4,807 | 3,043 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $5,081 | 3,043 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $5,142 | 3,043 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $2,769 | 3,043 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,369 | 3,043 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,521 | 3,043 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,769 | 3,043 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $3,043 | 3,043 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $4,503 | 3,043 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $3,316 | 3,043 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $3,590 | 3,043 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $4,290 | 3,043 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $4,564 | 3,043 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $3,560 | 3,043 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $3,438 | 3,043 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $4,807 | 3,043 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $4,686 | 3,043 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $7,455 | 3,043 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $7,668 | 3,043 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $8,672 | 3,043 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $5,355 | 3,043 | Shares | Sole | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||